Givaudan reported 2.41B in Current Liabilities for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 4407M 557M
Arkema AKE:FP € 1947M 194M
BASF BAS:GR € 20322M 788M
Bayer BAYN:GR € 28727M 801M
British American Tobacco BATS:LN 18.42B 2.94B
Covestro 1COV:GR 3.16B 251M
Croda International CRDA:LN 419.2M 73.8M
Diageo DGE:LN 7.14B 432M
DSM DSM:NA € 2264M 82M
Fresenius FRE:GR € 15352M 148M
Fresenius Medical Care FME:GR € 7492M 67.37M
Givaudan GIVN:VX 2.41B 618M
Glanbia GLB:ID 701.3M 17.8M
International Flavors Fragrances IFF:US $ 3579M 352M
Johnson Matthey JMAT:LN 3.58B 21M
Kerry Group KYG:ID 1.92B 222.4M
Lonza Group LONN:SW 3.11B 12M
Merck MRK:GR € 9793M 27M
SGS SGSN:VX 2.18B 456M
Solvay SOLB:BB € 4674M 1389M
Tate & Lyle TATE:LN 754M 197M
Umicore UMI:BB 4B 644.46M